
CSTL
Castle Biosciences Inc.
$24.01
+$0.55(+2.34%)
27
Overall
--
Value
27
Tech
--
Quality
Market Cap
$619.33M
Volume
518.80K
52W Range
$14.59 - $35.84
Target Price
$36.11
Order:
Income Statement
Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
Total Revenue | $51.9M | $62.6M | $94.1M | $137.0M | $219.8M | $332.1M | ||
Total Revenue | $51.9M | $62.6M | $94.1M | $137.0M | $219.8M | $332.1M | ||
COST OF GOODS SOLD | ||||||||
Cost of Revenue | $7.3M | $9.7M | $15.8M | $32.0M | $45.0M | $60.2M | ||
GROSS PROFIT | ||||||||
Gross Profit | $44.6M | $53.0M | $78.3M | $105.0M | $174.8M | $271.9M | ||
OPERATING EXPENSES | ||||||||
Operating Expenses | $39.4M | $59.5M | $134.2M | $196.2M | $242.8M | $263.2M | ||
Research & Development | $9.5M | $13.3M | $45.5M | $44.9M | $53.6M | $52.0M | ||
Research Expense | $9.5M | $13.3M | $29.6M | $44.9M | $53.6M | $52.0M | ||
Selling, General & Administrative | $29.8M | $48.1M | $86.7M | $143.0M | $180.2M | $200.0M | ||
General & Administrative Expenses | $29.8M | $48.1M | $86.7M | $143.0M | $180.2M | $200.0M | ||
Depreciation & Amortization | $-354.0K | $472.0K | $2.0M | $8.3M | $9.0M | $11.1M | ||
Depreciation & Amortization | $2.2M | $472.0K | $2.0M | $8.3M | $9.0M | $11.1M | ||
Amortization | $-1.9M | $839.0K | $2.0M | $8.3M | $9.0M | $11.1M | ||
Other Operating Expenses | -- | $-1.9M | $1.5M | -- | -- | -- | ||
OPERATING INCOME | ||||||||
Operating income | $5.2M | $-6.5M | $-40.1M | $-72.9M | $-68.0M | $8.7M | ||
EBITDA | $10.0M | $-7.1M | $-36.6M | $-58.3M | $-45.0M | $38.1M | ||
NON-OPERATING ITEMS | ||||||||
Interest Expense (Non-Operating) | $4.6M | $2.6M | $1.0K | $17.0K | $11.0K | $577.0K | ||
Interest Income Operating | $420.0K | -- | -- | -- | -- | -- | ||
Intinc | $312.0K | $373.0K | $68.0K | $4.0M | $10.6M | $12.9M | ||
Net Non-Operating Interest Income/Expense | $-4.3M | $-2.3M | $67.0K | $-4.0M | $10.6M | $12.3M | ||
Other Income/Expense | $-2.3M | $1.4M | -- | $18.3M | -- | $-600.0K | ||
Other Special Charges | $2.3M | $-1.4M | -- | -- | -- | -- | ||
PRE-TAX INCOME | ||||||||
EBIT | $7.8M | $-7.6M | $-40.0M | $-68.9M | $-57.4M | $22.1M | ||
Pre-Tax Income | $3.2M | $-10.2M | $-40.1M | $-68.9M | $-57.4M | $21.6M | ||
INCOME TAX | ||||||||
Tax Provision | $72.0K | $84.0K | $-8.7M | $-1.8M | $101.0K | $3.3M | ||
NET INCOME | ||||||||
Net Income | $3.1M | $-10.3M | $-31.3M | $-67.1M | $-57.5M | $18.2M | ||
Net Income (Continuing Operations) | $3.1M | $-10.3M | $-31.3M | $-67.1M | $-57.5M | $18.2M | ||
Net Income (Discontinued Operations) | $3.1M | $-10.3M | $-31.3M | $-67.1M | $-57.5M | $18.2M | ||
Net Income (Common Stockholders) | $3.0M | $-10.3M | $-31.3M | $-67.1M | $-57.5M | $18.2M | ||
Normalized Income | -- | -- | $-48.8M | -- | -- | -- | ||
TOTALS | ||||||||
Total Expenses | $46.7M | $69.2M | $150.0M | $228.2M | $287.8M | $323.4M | ||
SHARE & EPS DATA | ||||||||
Average Shares Outstanding | $8.6M | $18.9M | $25.1M | $26.1M | $26.8M | $27.8M | ||
Average Shares Outstanding (Diluted) | $8.7M | $18.9M | $25.1M | $26.1M | $26.8M | $29.3M | ||
Shares Outstanding | $17.2M | $25.0M | $29.0M | $26.6M | $27.4M | $28.5M | ||
Basic EPS | $0.35 | $-0.54 | $-1.24 | $-2.58 | $-2.14 | $0.66 | ||
Basic EPS (Continuing Operations) | $0.35 | $-0.54 | $-1.24 | $-2.58 | $-2.14 | $0.66 | ||
Diluted EPS | $-0.21 | $-0.54 | $-1.24 | $-2.58 | $-2.14 | $0.62 | ||
Diluted EPS (Continuing Operations) | $-0.21 | $-0.54 | $-1.24 | $-2.58 | $-2.14 | $0.62 | ||
OTHER METRICS | ||||||||
Accretion On Preferred Stock | $130.0K | -- | -- | -- | -- | -- | ||
Depletion | $2.2M | -- | -- | -- | -- | -- | ||
Development Expense | -- | -- | $15.8M | -- | -- | -- | ||
Other Gand A | $29.8M | $48.1M | $86.7M | $143.0M | $180.2M | $200.0M | ||
Otherunder Preferred Stock Dividend | $130.0K | -- | -- | -- | -- | -- | ||
Preferred Stock Dividends | $130.0K | -- | -- | -- | -- | -- | ||
Rent And Landing Fees | $-395.0K | $548.0K | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | CSTL | $24.01 | +2.3% | 518.80K |
3 | ||||
4 | ||||
5 | ||||
6 |